A previous study demonstrated that FGF9 attenuated myocardial infarction in diabetic mice by increasing the levels of anti-inflammatory cytokines and M2 macrophage differentiation, thereby reducing adverse remodeling and improving cardiac function [56]. This evidence concerns the gene FGF9 and myocardial infarction.